Publications Systematic Review: Disease Activity Indices for Immune Checkpoint Inhibitor-Associated Enterocolitis Citation Ma C, MacDonald JK, Nguyen TM, Chang J, Vande Casteele N, Feagan BG, Jairath V. Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis. Aliment Pharmacol Ther. 2022 Jan;55(2):178-190. DOI: 10.1111/apt.16718. Epub 2021 Nov 25. PMID: 34821404. Abstract Background: Although there is interest in developing pharmacotherapies for the treatment of immune checkpoint inhibitor-associated enterocolitis (ICIC), there is currently no consensus on how to optimally measure disease activity in this condition. Tags Adverse Effects, Crohn's Disease, Enterocolitis, Physiopathology, Ulcerative Colitis Read More